Sinopharm Suits Zimbabwe’s Cold Chain Capacity

UNLIKE other COVID-19 vaccines that were developed using  the Messenger Ribonucleic Acids (M-RNA) technology, vaccines manufactured using a killed/inactivated virus such as the Sinopharm, Sinovac and COVAXIN currently being administered in Zimbabwe do not require expensive subzero cold-chain infrastructure. By Michael Gwarisa The messenger RNA technology was deployed in the Pfizer, Mordena and other vaccines, making such vaccines unsuitable for hot climatic conditions such as the one in Zimbabwean unless the country installs a costly deep freeze airport warehouse, procures and modifies refrigerated vehicles and inoculation points to ensure the…

Read More

Zim COVID-19 Epidemic Curve Flattening – Dr Grant

Dr Grant Murewanhema

LOCAL Public Health Expert and Epidemiologist, Dr Grant Murewanhema has hinted that Zimbabwe’s epidemic curve was at the verge of flattening even though clustered sections of infections were still reported at community level. By Michael Gwarisa An epidemic curve, also known as an epi curve or epidemiological curve, is a statistical chart used to visualize the onset and progression of a disease outbreak. Presenting during an editors workshop that was organized by the National AIDS Council, Dr Grant said there was need to scale-up COVID-19 prevention interventions in  a bid…

Read More

#LongReadAhead: Vaccines Efficacy And Effectiveness Explained

Dr Tinashe Gede

THE arrival of the coronavirus on our shores has to a larger extent planted an appetite for reading and commenting around health-related issues even amongst non-medical people. All of a sudden everyone is now a public health or medical analyst and this is largely due to information gaps present in our communities. By Michael Gwarisa The World Health Organisation (WHO) identified information and communication as a key pillar to the pandemic response amongst the eight pillars the world heath body has set. However, when not managed and disseminated well, information…

Read More

WHO Zimbabwe Expert Clarifies On Sinopharm Vaccine, Says Sinopharm And More Other Vaccines Awaiting WHO Emergency Use Approval

There is nothing unusual about Sinopharm being administered before getting the WHO SAGE approval Only Four Vaccines have received the WHO EUL approval SAGE likely to make recommendations to Sinopharm end of March or beginning of April THE Sinopharm, Sinovac, Suptnik and at least 30 more other vaccines have submitted their dossiers to the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) for them to be listed for emergency use amidst indications that to date, only four vaccines namely the Pfizer Biotech, Astrazeneca, Mordena and Johnson & Johnson…

Read More

Intensify COVID-19 Prevention and Vaccination of Teachers and Pupils Health Experts Warn

THE World Health Organisation (WHO) Zimbabwe representative, Dr Alex Gasasira says there is need to support schools in ensuring they adhere to set COVID-19 prevention guidelines to avoid a spike in COVID-19 cases. By Patricia Mashiri The call comes hot on the heels of  the recent reopening of schools in the midst of concerns being raised by public health experts that the country could be headed for a catastrophic third wave in the midst of new COVID-19 strains. In an interview with HealthTimes, Dr  Gasasira, said schools should be supported…

Read More